Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.

Quotes for Spago Nanomedical AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Mats Hansen

Chairperson of the Board

  • Eugen Steiner

Board

  • Kari Grønås
  • Nicklas Westerholm
  • Peter Leander
  • Sten Nilsson

Videos

Largest Owners

Name Capital % Votes % Date
Peter Lindell 40,54 40,54 2024-01-29
Mikael Lönn 8,50 8,50 2024-01-29
Avanza Pension 5,48 5,48 2024-01-29
Eva Redhe 5,07 5,07 2024-01-29
Tiel Ridderstad 3,79 3,79 2024-01-29
Nordnet Pensionsförsäkring 2,37 2,37 2024-01-29
Anna Filippa Katarina Lindström 1,38 1,38 2024-01-29
Håkan Ekvall 1,15 1,15 2024-01-29
Futur Pension 0,99 0,99 2024-01-29
Dan Peters 0,92 0,92 2023-12-27